28 results on '"Riccardi, Carlo"'
Search Results
2. Dexamethasone-FITC staining application for measurement of circadian rhythmicity of glucocorticoid receptor expression in mouse living thymocyte subsets
- Author
-
Kowalik, Anna, Kiernozek, Ewelina, Kulinczak, Mariusz, Brodaczewska, Klaudia, Kozlowska, Ewa, Gieczewska, Katarzyna, Riccardi, Carlo, and Drela, Nadzieja
- Published
- 2013
- Full Text
- View/download PDF
3. Differential expression of CD44 isoforms during liver regeneration in rats
- Author
-
Della Fazia, Maria Agnese, Pettirossi, Valentina, Ayroldi, Emira, Riccardi, Carlo, Magni, Mariapia Viola, and Servillo, Giuseppe
- Published
- 2001
- Full Text
- View/download PDF
4. The radiosensitizer silver nanoparticles effects are prevent to ion channel blocker DIDS in U251 human glioblastoma cell line
- Author
-
Ragonese, Francesco, Arcuri, Cataldo, Mecca, Carmen, Mancinelli, Loretta, Albi, Elisabetta, Flamini, Sara, Bereshchenko, Oxana, Bruscoli, Stefano, Del Papa, Beatrice, Riccardi, Carlo, Sportoletti, Paolo, and Fioretti, Bernard
- Published
- 2017
- Full Text
- View/download PDF
5. A focused Real Time PCR strategy to determine GILZ expression in mouse tissues
- Author
-
Cari, Luigi, Ricci, Erika, Gentili, Marco, Petrillo, Maria Grazia, Ayroldi, Emira, Ronchetti, Simona, Nocentini, Giuseppe, and Riccardi, Carlo
- Published
- 2015
- Full Text
- View/download PDF
6. GILZ Promotes Production of Peripherally Induced Treg Cells and Mediates the Crosstalk between Glucocorticoids and TGF-β Signaling.
- Author
-
Bereshchenko, Oxana, Coppo, Maddalena, Bruscoli, Stefano, Biagioli, Michele, Cimino, Monica, Frammartino, Tiziana, Sorcini, Daniele, Venanzi, Alessandra, Di Sante, Moises, and Riccardi, Carlo
- Abstract
Summary: Regulatory T (Treg) cells expressing the transcription factor forkhead box P3 (FoxP3) control immune responses and prevent autoimmunity. Treatment with glucocorticoids (GCs) has been shown to increase Treg cell frequency, but the mechanisms of their action on Treg cell induction are largely unknown. Here, we report that glucocorticoid-induced leucine zipper (GILZ), a protein induced by GCs, promotes Treg cell production. In mice, GILZ overexpression causes an increase in Treg cell number, whereas GILZ deficiency results in impaired generation of peripheral Treg cells (pTreg), associated with increased spontaneous and experimental intestinal inflammation. Mechanistically, we found that GILZ is required for GCs to cooperate with TGF-β in FoxP3 induction, while it enhances TGF-β signaling by binding to and promoting Smad2 phosphorylation and activation of FoxP3 expression. Thus, our results establish an essential GILZ-mediated link between the anti-inflammatory action of GCs and the regulation of TGF-β-dependent pTreg production. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
7. Glucocorticoid-Induced Leucine Zipper (GILZ) Over-Expression in T Lymphocytes Inhibits Inflammation and Tissue Damage in Spinal Cord Injury.
- Author
-
Esposito, Emanuela, Bruscoli, Stefano, Mazzon, Emanuela, Paterniti, Irene, Coppo, Maddalena, Velardi, Enrico, Cuzzocrea, Salvatore, and Riccardi, Carlo
- Subjects
GLUCOCORTICOIDS ,LEUCINE zippers ,T cells ,INFLAMMATION ,SPINAL cord injuries - Abstract
Spinal cord injury (SCI) is a traumatic event that causes a secondary and extended inflammation characterized by infiltration of immune cells, including T lymphocytes, release of pro-inflammatory mediators in the lesion site, and tissue degeneration. Current therapeutic approaches for SCI are limited to glucocorticoids (GC) due to their potent anti-inflammatory activity. GC efficacy resides, in part, in the capability to inhibit NF-κB, T lymphocyte activation, and the consequent cytokine production. In this study, we performed experiments aimed to test the susceptibility of glucocorticoid-induced leucine zipper (GILZ) transgenic (GILZ) mice, in which GILZ is selectively over-expressed in T lymphocytes, to SCI induction. Consistent with a decreased inflammatory response, GILZ were less susceptible to SCI as compared to wild-type littermates. Notably, inhibition of NF-κB activation and nuclear translocation, diminished T lymphocytes activation and tissue infiltration, as well as decreased release of cytokines were evident in GILZ as compared to wild-type mice. Moreover, GILZ showed a reduced tumor necrosis factor-α, IL-1β, Inductible nitric oxide synthase (iNOS) and nytrotyrosine production, apoptosis, and neuronal tissue damage. Together these results indicate that GILZ mimics the anti-inflammatory effect of GC and represents a potential pharmacological target for modulation of T lymphocyte-mediated immune response in inflammatory disorders, such as SCI. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
8. Glucocorticoid-Induced Leucine Zipper Is Protective in Th1-Mediated Models of Colitis.
- Author
-
Cannarile, Lorenza, Cuzzocrea, Salvatore, Santucci, Luca, Agostini, Massimiliano, Mazzon, Emanuela, Esposito, Emanuela, Muià, Carmelo, Coppo, Maddalena, Di Paola, Rosanna, and Riccardi, Carlo
- Subjects
LEUCINE zippers ,GLUCOCORTICOIDS ,COLITIS prevention ,INFLAMMATORY bowel diseases ,GASTROINTESTINAL diseases ,LABORATORY mice ,TUMOR necrosis factors ,T-cell receptor genes - Abstract
Background & Aims: Inflammatory bowel diseases are relatively common diseases of the gastrointestinal tract. The relative therapeutic efficacy of glucocorticoids used in inflammatory bowel diseases resides in part in their capability to inhibit activity of nuclear factor κB (NF-κB), a transcription factor central to the inflammatory process, and the consequent production of T-helper 1 (Th1)-type cytokines. Previous studies indicate that increased expression in transgenic mice of glucocorticoid-induced leucine zipper (GILZ), a gene rapidly induced by glucocorticoids, inhibits NF-κB and Th1 activity. Methods: We performed experiments with the aim to test the susceptibility of GILZ transgenic (GILZ-TG) mice to dinitrobenzene sulfonic acid–induced colitis. Results: Consistent with a decreased Th1 response, GILZ-TG mice were less susceptible to colitis induction as compared with wild-type littermates, while they were more susceptible to Th2-mediated colitis. The inhibition was comparable to that obtained with dexamethasone treatment. Moreover, diminished intestinal tissue damage, associated with inhibition of NF-κB nuclear translocation, interferon-γ, tumor necrosis factor-α, and interleukin-1 production in CD4
+ T lymphocytes of the lamina propria, was evident in GILZ-TG as compared with wild-type mice. In addition, inhibition of colitis development was also evident when GILZ fusion protein was delivered in vivo in dinitrobenzene sulfonic acid–treated WT animals as well as in interleukin-10 knockout mice. Conclusions: Together these results demonstrate that GILZ mimics the effects of glucocorticoids, suggesting a contribution of this protein to the anti-inflammatory activity of glucocorticoids in Th1-induced colitis. [Copyright &y& Elsevier]- Published
- 2009
- Full Text
- View/download PDF
9. Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells.
- Author
-
Ceccarelli, Veronica, Ronchetti, Simona, Marchetti, Maria Cristina, Calvitti, Mario, Riccardi, Carlo, Grignani, Francesco, and Vecchini, Alba
- Abstract
DNA methylation and histone acetylation, the most studied epigenetic changes, drive and maintain cancer phenotypes. DNA methyltransferase (DNMT) dysregulation promoted localized hypermethylation in CpG rich regions while upregulated histone deacetylases (HDAC) deacetylated histone tails. Both changes led to close chromatin conformation, suppressing transcription and silencing tumor suppressor genes. Consequently, HDAC and DNMT inhibitors appeared to reprogram the transcriptional circuit and potentiate anti-tumoral activity. Here, we report that eicosapentaenoic acid (EPA), a fatty acid with anti-cancer properties, inhibited HDAC1 and DNMT expression and activity, thus promoting tumor suppressor gene expression. In hepatocarcinoma cells (HCC) EPA bound and activated PPARγ thus downregulating HDAC1 which sequentially reduced expression of DNMT1, 3A and 3B. At the same time, activated PPARγ physically interacted with DNMT1 and HDAC1 in a CpG island on the Hic-1 gene to assemble PPARγ/DNMT1 and PPARγ/HDAC1 protein complexes, which exited from DNA. When EPA and PPARγ were no longer bound, the protein complexes separated into individual proteins. Consequently, DNMT1 and HDAC1 down-regulation and release from DNA inhibited their activities. Overall, EPA-bound PPARγ induced re-expression of the tumor suppressor gene Hic-1. In the present study PPARγ emerged as a master regulator acting synergistically through diverse targets and ways to reveal the epigenetic action of EPA as an HDAC1 and DNMT1 inhibitor. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
10. GITR cosignal in ILC2s controls allergic lung inflammation.
- Author
-
Nagashima, Hiroyuki, Okuyama, Yuko, Fujita, Tsuyoshi, Takeda, Takeo, Motomura, Yasutaka, Moro, Kazuyo, Hidaka, Takanori, Omori, Koki, Sakurai, Tsuyoshi, Machiyama, Tomoaki, Ndhlovu, Lishomwa C., Riccardi, Carlo, So, Takanori, and Ishii, Naoto
- Published
- 2018
- Full Text
- View/download PDF
11. Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleen
- Author
-
Herberman, Ronald B., Hiserodt, John, Vujanovic, Nicola, Balch, Charles, Lotzova, Eva, Bolhuis, Reinder, Golub, Sidney, Lanier, Lewis L., Phillips, Joseph H., Riccardi, Carlo, Ritz, Jerome, Santoni, Angela, Schmidt, Reinholdt E., and Uchida, Atsushi
- Published
- 1987
- Full Text
- View/download PDF
12. Exploiting the pro-resolving actions of glucocorticoid-induced proteins Annexin A1 and GILZ in infectious diseases.
- Author
-
Vago, Juliana P., Tavares, Luciana P., Riccardi, Carlo, Teixeira, Mauro M., and Sousa, Lirlândia P.
- Subjects
- *
COMMUNICABLE diseases , *INFLAMMATION , *OPPORTUNISTIC infections , *LEUCINE zippers , *ANIMAL models in research , *EMERGING infectious diseases - Abstract
• GILZ and AnxA1 are involved with the anti-inflammatory functions of glucocorticoids without the associated adverse metabolic effects. • GILZ and AnxA1 coordinate the resolution of inflammation and promote host defense in infectious diseases. • GILZ and AnxA1 may be useful pharmacological adjunctive therapies to antibiotics in the context of infectious diseases. For decades, glucocorticoids (GC) have been used to treat several inflammatory conditions, including chronic and autoimmune diseases, due to their potent anti-inflammatory properties. In the context of infectious diseases, the use of GCs may be effective as adjuvant to antibiotic therapy by controlling excessive inflammatory responses resulting in better outcome in some cases. However, the use of GCs has been associated with a vast number of side effects, including increased probability of immunosuppression and consequent risk of opportunistic infection. Glucocorticoid-induced leucine zipper (GILZ) and Annexin A1 (AnxA1) are GC-induced proteins intrinsically involved with the anti-inflammatory functions of GCs without the associated adverse metabolic effects. Recent studies have shown that these GC-proteins exhibit pro-resolving effects. An essential characteristic of pro-resolving molecules is their ability to coordinate the resolution of inflammation and promote host defense in most experimental models of infection. Although the role of GILZ and AnxA1 in the context of infectious diseases remain to be better explored, herein we provide an overview of the emerging functions of these GC-proteins obtained from pre-clinical models of infectious diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR).
- Author
-
Platania, Chiara Bianca Maria, Ronchetti, Simona, Riccardi, Carlo, Migliorati, Graziella, Marchetti, Maria Cristina, Di Paola, Luisa, Lazzara, Francesca, Drago, Filippo, Salomone, Salvatore, and Bucolo, Claudio
- Subjects
- *
GLUCOCORTICOIDS , *TUMOR necrosis factors , *TUMOR necrosis factor receptors , *CROHN'S disease , *MOLECULAR structure , *SMALL molecules , *T cells , *MONOCLONAL antibodies - Abstract
The tumor necrosis factor (TNF) superfamily (TNFSF) includes about thirty structurally related receptors (TNFSFRs) and about twenty protein ligands that bind to one or more of these receptors. Receptors of the tumor necrosis factor (TNF) superfamily (TNFSFRs) are pharmacological targets for treatment of inflammatory and autoimmune diseases. Currently, drugs targeting TNFSFR signaling are biological drugs (monoclonal antibodies, decoy receptors) aimed at binding and sequestering TNFSFR ligands. The glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) signaling is involved in a series of inflammatory and autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. Our study aimed at repurposing FDA approved small molecules as protein–protein disruptors at the GITR ligand (GITRL) trimer, in order to inhibit the binding of GITRL to its receptor (GITR). A structure based molecular modeling approach was carried out to identify, through high throughput virtual screening, GITRL monomer–monomer disruptors. We used a database of ~8,000 FDA approved drugs, and after virtual screening, we focused on two hit compounds, minocycline and oxytetracycline. These two compounds were tested for their capability to modulate IL-17, IL-21 and RORγT expression in T lymphocytes, isolated from wild-type and GITR knock-out (GITR−/−) mice. Minocycline showed immunomodulatory effects specific to GITR activation and could represent a novel pharmacological tool to treat inflammatory diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
14. Aberrant expression of β-catenin in CD4+ T cells isolated from primary progressive multiple sclerosis patients.
- Author
-
Giacoppo, Sabrina, Bereshchenko, Oxana, Bruscoli, Stefano, Riccardi, Carlo, Bramanti, Placido, and Mazzon, Emanuela
- Subjects
- *
MULTIPLE sclerosis treatment , *CATENINS , *NEUROLOGICAL disorders , *CD4 antigen , *TARGETED drug delivery , *WESTERN immunoblotting - Abstract
Primary progressive multiple sclerosis (PP-MS) is a less common progressive form of MS in approximately 10% of patients that manifest increasingly neurological disability from disease onset. To date, there are no approved treatments for the progressive stage. Therefore, identifying new therapeutic targets could open a new opportunity for PP-MS management. Several lines of evidence suggest the critical role of the Wnt/β-catenin pathway in immune-mediated diseases, like MS. This study was aimed to investigate whether aberrant expression of β-catenin is involved in PP-MS progression. By western blot analysis the expression of β-catenin was evaluated in CD4 + cells purified from peripheral blood of PP-MS patients. Specifically, nuclear expression of β-catenin was detected in CD4 + T cells purified from peripheral blood lymphocytes of PP-MS, and not of other neuromuscular diseases. In addition, no relevant expression of Wnt-1 was found in PP-MS patients, suggesting that the increase in nuclear β-catenin expression in these cells could be independent from canonical Wnt pathway. Taken together, our observations demonstrate that the deregulation of the β-catenin expression is involved in CD4 + T cells of PP-MS patients. Therefore, inhibitors of β-catenin pathway could be proposed as a promising candidate strategy for PP-MS cure. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
15. Induction of Glucocorticoid-induced Leucine Zipper (GILZ) Contributes to Anti-inflammatory Effects of the Natural Product Curcumin in Macrophages.
- Author
-
Hoppstädter, Jessica, Hachenthal, Nina, Valbuena-Perez, Jenny Vanessa, Lampe, Sebastian, Astanina, Ksenia, Kunze, Michael M., Bruscoli, Stefano, Riccardi, Carlo, Schmid, Tobias, Diesel, Britta, and Kiemer, Alexandra K.
- Subjects
- *
GLUCOCORTICOIDS , *LEUCINE zippers , *ANTI-inflammatory agents , *NATURAL products , *CURCUMIN , *MACROPHAGES , *BIOCHEMICAL mechanism of action , *MITOGEN-activated protein kinases , *THERAPEUTICS - Abstract
GILZ (glucocorticoid-induced leucine zipper) is inducible by glucocorticoids and plays a key role in their mode of action. GILZ attenuates inflammation mainly by inhibition of NF-κB and mitogen-activated protein kinase activation but does not seem to be involved in the severe side effects observed after glucocorticoid treatment. Therefore, GILZ might be a promising target for new therapeutic approaches. The present work focuses on the natural product curcumin, which has previously been reported to inhibit NF-κB. GILZ was inducible by curcumin in macrophage cell lines, primary human monocyte-derived macrophages, and murine bone marrow-derived macrophages. The up-regulation of GILZ was neither associated with glucocorticoid receptor activation nor with transcriptional induction or mRNA or protein stabilization but was a result of enhanced translation. Because the GILZ 3-UTR contains AU-rich elements (AREs), we analyzed the role of the mRNA-binding protein HuR, which has been shown to promote the translation of ARE-containing mRNAs. Our results suggest that curcumin treatment induces HuR expression. An RNA immunoprecipitation assay confirmed that HuR can bind GILZ mRNA. In accordance, HuR overexpression led to increased GILZ protein levels but had no effect on GILZ mRNA expression. Our data employing siRNA in LPS-activated RAW264.7 macrophages show that curcumin facilitates its anti-inflammatory action by induction of GILZ in macrophages. Experiments with LPS-activated bone marrow-derived macrophages from wild-type and GILZ knock-out mice demonstrated that curcumin inhibits the activity of inflammatory regulators, such as NF-κB or ERK, and subsequent TNF-α production via GILZ. In summary, our data indicate that HuR-dependent GILZ induction contributes to the anti-inflammatory properties of curcumin. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
16. GITR+ regulatory T cells in the treatment of autoimmune diseases.
- Author
-
Petrillo, Maria Grazia, Ronchetti, Simona, Ricci, Erika, Alunno, Alessia, Gerli, Roberto, Nocentini, Giuseppe, and Riccardi, Carlo
- Subjects
- *
GLUCOCORTICOIDS , *TUMOR necrosis factor receptors , *T cells , *AUTOIMMUNE disease treatment , *LIFE expectancy , *DRUG side effects , *IMMUNOSUPPRESSIVE agents - Abstract
Autoimmune diseases decrease life expectancy and quality of life for millions of women and men. Although treatments can slow disease progression and improve quality of life, all currently available drugs have adverse effects and none of them are curative; therefore, requiring patients to take immunosuppressive drugs for the remainder of their lives. A curative therapy that is safe and effective is urgently needed. We believe that therapies promoting the in vivo expansion of regulatory T cells (Tregs) or injection of in vitro expanded autologous/heterologous Tregs (cellular therapy) can alter the natural history of autoimmune diseases. In this review, we present data from murine and human studies suggesting that 1) glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR) plays a crucial role in thymic Treg (tTreg) differentiation and expansion; 2) GITR plays a crucial role in peripheral Treg (pTreg) expansion; 3) in patients with Sjögren syndrome and systemic lupus erythematosus, CD4 + GITR + pTregs are expanded in patients with milder forms of the disease; and 4) GITR is superior to other cell surface markers to differentiate Tregs from other CD4 + T cells. In this context, we consider two potential new approaches for treating autoimmune diseases consisting of the in vivo expansion of GITR + Tregs by GITR-triggering drugs and in vitro expansion of autologous or heterologous GITR + Tregs to be infused in patients. Advantages of such an approach, technical problems, and safety issues are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
17. Long Glucocorticoid-induced Leucine Zipper (L-GILZ) Protein Interacts with Ras Protein Pathway and Contributes to Spermatogenesis Control.
- Author
-
Bruscoli, Stefano, Velardi, Enrico, Di Sante, Moises, Bereshchenko, Oxana, Venanzi, Alessandra, Coppo, Maddalena, Berno, Valeria, Mameli, Maria Grazia, Colella, Renato, Cavaliere, Antonio, and Riccardi, Carlo
- Subjects
- *
SPERMATOGENESIS , *GERM cells , *CELL proliferation , *GLUCOCORTICOIDS , *APOPTOSIS - Abstract
Correct function of spermatogonia is critical for the maintenance of spermatogenesis throughout life, but the cellular pathways regulating undifferentiated spermatogonia proliferation, differentiation, and survival are only partially known. We show here that long glucocorticoid-induced leucine zipper (L-GILZ) is highly expressed in spermatogonia and primary spermatocytes and controls spermatogenesis. Gilz deficiency in knockout (gilz KO) mice leads to a complete loss of germ cell lineage within first cycles of spermatogenesis, resulting in male sterility. Spermatogenesis failure is intrinsic to germ cells and is associated with increased proliferation and aberrant differentiation of undifferentiated spermatogonia and with hyperactivity of Ras signaling pathway as indicated by an increase of ERK and Akt phosphorylation. Spermatogonia differentiation does not proceed beyond the prophase of the first meiotic division due to massive apoptosis associated with accumulation of unrepaired chromosomal damage. These results identify L-GILZ as a novel important factor for undifferentiated spermatogonia function and spermatogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
18. Eicosapentaenoic Acid Demethylates a Single CpG That Mediates Expression of Tumor Suppressor CCAAT/Enhancer-binding Protein δ in U937 Leukemia Cells.
- Author
-
Ceccarelli, Veronica, Racanicchi, Serena, Martelli, Maria Paola, Nocentini, Giuseppe, Fettucciari, Katia, Riccardi, Carlo, Marconi, Pierfrancesco, Di Nardo, Paolo, Grignani, Francesco, Binaglia, Luciano, and Vecchini, Alba
- Subjects
- *
EICOSAPENTAENOIC acid , *TUMOR suppressor proteins , *UNSATURATED fatty acids , *CELL cycle ,LEUKEMIA genetics - Abstract
Polyunsaturated fatty acids (PUFAs) inhibit proliferation and induce differentiation in leukemia cells. To investigate the molecular mechanisms whereby fatty acids affect these processes, U937 leukemia cells were conditioned with stearic, oleic, linolenic, α-linolenic, arachidonic, eicosapentaenoic, and docosahexaenoic acids. PUFAs affected proliferation; eicosapentaenoic acid (EPA) was the most potent on cell cycle progression. EPA enhanced the expression of the myeloid lineage-specific transcription factors CCAAT/enhancer-binding proteins (C/EBPβ and C/EBPδ), PU.1, and c-Jun, resulting in increased expression of the monocyte lineage-specific target gene, the macrophage colony-stimulating factor receptor. Indeed, it is known that PU.1 and C/EBPs interact with their consensus sequences on a small DNA fragment of macrophage colony-stimulating factor receptor promoter, which is a determinant for expression. We demonstrated that C/EBPβ and C/EBPδ bind the same response element as a heterodimer. We focused on the enhanced expression of C/EBPδ, which has been reported to be a tumor suppressor gene silenced by promoter hypermethylation in U937 cells. After U937 conditioning with EPA and bisulfite sequencing of the −370/−20 CpG island on the C/EBPδ promoter region, we found a site-specific CpG demethylation that was a determinant for the binding activity of Sp1, an essential factor for C/EBPδ gene basal expression. Our results provide evidence for a new role of PUFAs in the regulation of gene expression. Moreover, we demonstrated for the first time that re-expression of the tumor suppressor C/EBPδ is controlled by the methylation state of a site-specific CpG dinucleotide. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
19. Glucocorticoid-Induced TNFR family Related gene (GITR) enhances dendritic cell activity
- Author
-
Ronchetti, Simona, Nocentini, Giuseppe, Petrillo, Maria Grazia, Bianchini, Rodolfo, Sportoletti, Paolo, Bastianelli, Alessandra, Ayroldi, Emira M., and Riccardi, Carlo
- Subjects
- *
GLUCOCORTICOID receptors , *DENDRITIC cells , *IMMUNE response , *T cells , *LABORATORY mice , *GENETIC regulation - Abstract
Abstract: Glucocorticoid-Induced TNFR family Related gene (GITR), a Tumor Necrosis Factor Receptor Superfamily (TNFRSF) member involved in immune/inflammatory processes, has been previously shown to regulate T cell activation. To study GITR role in antigen presenting cells, we evaluated the capability of bone marrow derived dendritic cells (BMDC) from GITR−/− mice to stimulate the activation of CD4+CD25− T lymphocytes. We found that GITR−/− BMDC are weaker stimulators of T cell proliferation than GITR+/+ BMDC, either in syngenic or allogenic BMDC/T cell co-cultures. Expression of GITR in GITR−/− BMDC restored their ability to activate T cells while GITR silencing in GITR+/+ BMDC inhibited the capability to stimulate T cells. GITR−/− BMDC showed a reduced production of the pro-inflammatory cytokine IL-6 and an increased production of the anti-inflammatory cytokine IL-10. Notably, co-culture of CD4+CD25− cells with GITR−/− BMDC originated FoxP3+ cells, secreting IL-10 and TGF-β. Finally, in vivo injection of GITR−/− OVA-loaded BMDC led to a lower cell number and a lower activated cell number in draining lymph nodes than in GITR+/+ OVA-loaded BMDC injected mice. Together, these results indicate that GITR plays a role in regulating BMDC activity. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
20. Glucocorticoid-induced Leucine Zipper (GILZ) and Long GILZ Inhibit Myogenic Differentiation and Mediate Anti-myogenic Effects of Glucocorticoids.
- Author
-
Bruscoli, Stefano, Donato, Valerio, Velardi, Enrico, Di Sante, Moises, Migliorati, Graziella, Donato, Rosario, and Riccardi, Carlo
- Subjects
- *
LEUCINE zippers , *GLUCOCORTICOIDS , *MYOGENESIS , *DNA-binding proteins , *TRANSCRIPTION factors - Abstract
Myogenesis is a process whereby myoblasts differentiate and fuse into multinucleated myotubes, the precursors of myofibers. Various signals and factors modulate this process, and glucocorticoids (GCs) are important regulators of skeletal muscle metabolism. We show that glucocorticoid-induced leucine zipper (GILZ), a GC-induced gene, and the newly identified isoform long GILZ (L-GILZ) are expressed in skeletal muscle tissue and in C2C12 myoblasts where GILZ/L-GILZ maximum expression occurs during the first few days in differentiation medium. Moreover, we observed that GC treatment of myoblasts, which increased GILZ/L-GILZ expression, resulted in reduced myotube formation, whereas GILZ and L-GILZ silencing dampened GC effects. Inhibition of differentiation caused by GILZ/L-GILZ overexpression correlated with inhibition of MyoD function and reduced expression of myogenin. Notably, results indicate that GILZ and L-GILZ bind and regulate MyoD/HDAC1 transcriptional activity, thus mediating the anti-myogenic effect of GCs. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
21. Identification of regulatory T cells in systemic lupus erythematosus
- Author
-
Gerli, Roberto, Nocentini, Giuseppe, Alunno, Alessia, Bocci, Elena Bartoloni, Bianchini, Rodolfo, Bistoni, Onelia, and Riccardi, Carlo
- Subjects
- *
T cells , *SYSTEMIC lupus erythematosus , *IMMUNOREGULATION , *PHENOTYPES , *AUTOIMMUNE diseases , *GENE expression , *TRANSCRIPTION factors , *BIOMARKERS - Abstract
Abstract: The concept that regulatory T cells (Treg) play a key role in both development and maintenance of autoimmune response in rheumatic diseases is well accepted. In recent years, several studies analyzed Treg cell phenotype and function in systemic lupus erythematosus (SLE), the prototypical systemic autoimmune disorder in humans. Although qualitative and/or quantitative abnormalities of Treg cells have been shown, data are often conflicting. This may depend on the selection of patients with different degrees of disease activity or on immunosuppressive treatments that can alter Treg cell findings. Among several proposed surface or intracellular Treg cell markers, CD25 at high level of expression and the transcription factor Foxp3 are the two most investigated in SLE. Despite the glucocorticoid-induced TNF receptor-related protein (GITR) represents a reliable phenotypic marker of murine Treg cells, little is known about its role in humans, in particular in the course of systemic autoimmune disorders. Preliminary data seems to suggest that this marker may represent a good tool to identify cell populations included within Treg cell subsets. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
22. Inhibited cell death, NF-κB activity and increased IL-10 in TCR-triggered thymocytes of transgenic mice overexpressing the glucocorticoid-induced protein GILZ
- Author
-
Delfino, Domenico Vittorio, Agostini, Massimiliano, Spinicelli, Stefania, Vacca, Carmine, and Riccardi, Carlo
- Subjects
- *
APOPTOSIS , *CELL death , *TRANSGENIC mice , *GLUCOCORTICOIDS , *LABORATORY mice - Abstract
Abstract: Glucocorticoids promote thymocyte apoptosis and modulate transcription of several genes including GILZ, which is strongly up-regulated in the thymus. We used transgenic mice overexpressing GILZ in the T-cell lineage to investigate TCR-triggered functions of GILZ-overexpressing thymocytes. TCR-triggered apoptosis, but not glucocorticoid-induced apoptosis, was inhibited in transgenic mice compared to their controls. In vivo anti-CD3 administration did not reduce CD4+CD8+ thymocyte number. Analysis of TCR-triggered molecular changes indicated that p65 NF-κB nuclear translocation and DNA binding activity was inhibited in transgenic mice, which might be linked with apoptosis inhibition. IL-10 release increased whereas release of IL-2, IFN-γ, IL-13 and IL-4 remained unchanged. These results support the hypothesis that GILZ regulates, at least in part, T-cell development by influencing thymus function at cellular and molecular levels. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
23. Genomic and non-genomic effects of different glucocorticoids on mouse thymocyte apoptosis
- Author
-
Bruscoli, Stefano, Di Virgilio, Rosa, Donato, Valerio, Velardi, Enrico, Baldoni, Monia, Marchetti, Cristina, Migliorati, Graziella, and Riccardi, Carlo
- Subjects
- *
APOPTOSIS , *ANTI-inflammatory agents , *ADRENOCORTICAL hormones , *AMINO acids - Abstract
Abstract: Glucocorticoids, widely used therapeutic agents for several pathologies, act upon diverse cells and tissues, including the lympho-haemopoietic system. Glucocorticoid-mediated apoptosis has been described as one of the mechanisms underlying their pharmacological and physiological effects. Glucocorticoids induce apoptosis in thymocytes through genomic and non-genomic signals. We tested thymocyte apoptosis rates as induced by a panel of glucocorticoids. Using four glucocorticoids that are widely adopted in clinical practice we compared their induction of thymocyte apoptosis and activation of non-genomic and genomic signals, including phosphatidylinositol–specific phospholipase C (PI–PLC), caspase-8, -9 and -3, and Glucocorticoid-Induced Leucine Zipper (GILZ). GILZ is a protein that is rapidly induced by glucocorticoids treatment and involved in apoptosis modulation. Results indicate different glucocorticoids have different apoptotic activity which is related to their ability to induce both genomic, evaluated as caspases activation and GILZ expression, and non-genomic effects, evaluated as PI–PLC phosphorylation. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
24. Dietary PUFA modulate the expression of proliferation and differentiation markers in Morris 3924A hepatoma cells
- Author
-
Vecchini, Alba, Ceccarelli, Veronica, Nocentini, Giuseppe, Riccardi, Carlo, Di Nardo, Paolo, and Binaglia, Luciano
- Subjects
- *
ESSENTIAL fatty acids , *LIVER tumors , *LINOLENIC acids , *MESSENGER RNA - Abstract
Abstract: The effect of dietary polyunsaturated fatty acids on the expression of differentiation and proliferation markers in Morris 3924A hepatoma cells was investigated. ACT/I rats were conditioned 10 days with diets enriched with linoleic acid or α-linolenic acid before subcutaneous hepatoma cell transplantation. After 19 days from the inoculum, the mRNA levels of liver-enriched transcription factors and of their target genes were quantified. Both linoleic acid- and linolenic acid-enriched diets induced a decrease of β-actin, AFP, PCNA, c-myc and of hepatocyte nuclear factors HNF-1α and HNF-4α mRNA levels in tumor tissue whereas HNF-3β expression was induced by both dietary treatments. Only the α-linolenic acid-enriched diet was effective in reducing c-jun and increasing albumin mRNA levels. Since albumin is a C/EBPα target gene, C/EBPα gene transcription was evaluated at both protein and mRNA levels. It was found that α-linolenic acid-enriched diet did not enhance the C/EBPα mRNA content in hepatoma tissue while inducing C/EBPα protein expression with an isoform pattern similar to the hepatic phenotype. This evidence implies that α-linolenic acid or one of its metabolic products induce albumin synthesis in hepatoma cells by modulating C/EBPα gene expression at post-transcriptional level. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
25. Glucocorticoid-induced Tumor Necrosis Factor Receptor Is a p21 Cip1/WAF1 Transcriptional Target Conferring Resistance of Keratinocytes to UV Light-induced Apoptosis.
- Author
-
Jian Wang, Devgan, Vikram, Corrado, Marcella, Prabhu, Nita S., El-Deiry, Wafik S., Riccardi, Carlo, Pandolfi, Pier Paolo, Missero, Caterina, and Dotto, G. Paolo
- Subjects
- *
GLUCOCORTICOIDS , *TRIAMCINOLONE , *ADRENOCORTICAL hormones , *TUMOR necrosis factors , *GLYCOPROTEINS , *GROWTH factors , *MESSENGER RNA , *KERATINOCYTES , *APOPTOSIS - Abstract
Glucocorticoid-induced tumor necrosis factor receptor (GITR) is a member of the tumor necrosis factor receptor superfamily, is expressed in T lymphocytes, and exerts an anti-apoptotic function in these cells. We reported that GITR is also highly expressed in the skin, specifically in keratinocytes, and that it is under negative transcriptional control of p21Cip1/WAF1, independently from the cell cycle. Although GITR expression is higher in p21-deficient keratinocytes and skin, it is down-modulated with differentiation and in response to UVB. The combined analysis of keratinocytes with increased GITR expression versus normal keratinocytes and skin of mice with a disruption of the GITR gene indicates that this protein protects keratinocytes from UVB-induced apoptosis both in vitro and in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
26. Synthesis and evaluation of anti-apoptotic activity of L-carnitine cyclic analogues and amino acid derivatives
- Author
-
Fringuelli, Renata, Utrilla Navarro, M. Pilar, Milanese, Lara, Bruscoli, Stefano, Schiaffella, Fausto, Riccardi, Carlo, and De Simone, Claudio
- Subjects
- *
CARNITINE , *ORNITHINE , *AMINO acids , *APOPTOSIS , *VITAMIN B complex - Abstract
Two series of derivatives were synthesised. In one series (R)-4-hydroxy-2-pyrrolidinone was used as a mimic of cyclic L-carnitine analogue and in the second series 3-amino-2-piperidinone was used as a cyclic ornithine analogue. N-Benzyloxycarbonyl derivatives of some amino acids were also prepared. The newly synthesised compounds were tested for their ability to inhibit Fas-activated apoptosis of human Jurkatt T-cell line. The results confirm the previously described anti-apoptotic activity of carnitine and indicate new carnitine and amino acid analogues (1, 3, 6, 7, 20) that inhibit Fas-induced apoptosis. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
27. 1,4-Benzothiazine analogues and apoptosis: structure–activity relationship
- Author
-
Fringuelli, Renata, Schiaffella, Fausto, Utrilla Navarro, M. Pilar, Milanese, Lara, Santini, Cristina, Rapucci, Michela, Marchetti, Cristina, and Riccardi, Carlo
- Subjects
- *
BENZOTHIAZINE , *THYMUS , *APOPTOSIS - Abstract
We have previously shown 1,4-benzothiazine (1,4-B) derivatives induce thymocyte apoptosis in vitro and thymus cell loss in vivo. Apoptosis is mediated through a complex of biochemical events including phosphatidylcholine specific-phospholipase C (PC-PLC) activation, acidic sphingomyelinase (aSMase) activation and ceramide generation, caspase-8 and caspase-3 activation. As preliminary analysis of the structure–activity relationship (SAR) suggested some structural features were responsible for apoptosis, we synthesised several derivatives and tested for apoptosis activity at equimolar concentrations. In particular, we synthesised analogues that differed in the nature of skeleton (1,4-benzothiazine, 1,4-benzoxazine and 1,2,3,4-tetrahydroquinoline) and in the nature of side chain (imidazole, benzimidazole or piperazine as azole substituent; presence, absence or transformation of alcoholic group). Results of apoptosis induction indicate that transforming the 1,4-benzothiazine skeleton into 1,2,3,4-tetrahydroquinoline does not result in significant change. Transformation into 1,4-benzoxazine decreased activity. Replacing imidazole at the side chain with different piperazines also decreased activity while replacing it with benzimidazole does not change apoptotic activity. Finally, removal of the alcoholic group by dehydration to olefin, or by transforming it into ether, increased activity. Moreover, in an attempt to analyse further the SAR characteristics that are responsible for 1,4-B-activated apoptosis we tested the effect on caspase-8,-9 and-3 activation. 1,4-B analogues activate caspases and the structural requirements correlate with those responsible for apoptosis induction. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
28. Dexamethasone-induced thymocytes apoptosis requires glucocorticoid receptor nuclear translocation but not mitochondrial membrane potential transition
- Author
-
Marchetti, Maria Cristina, Marco, Barbara Di, Santini, Maria Cristina, Bartoli, Andrea, Delfino, Domenico Vittorio, and Riccardi, Carlo
- Subjects
- *
APOPTOSIS , *GLUCOCORTICOIDS - Abstract
Dexamethasone (DEX), a glucocorticoid hormone (GCH) with specificity for the glucocorticoid receptor (GR) induces T lymphocyte and thymocyte apoptosis. DEX-activated thymocyte apoptosis requires a sequence of biochemical events including mRNA and protein synthesis. In particular, GCH treatment induces non-genomic mechanisms, such as for example Ca2+ mobilization and PI-PLC activation, and genomic mechanisms. Most of these events, including protein synthesis, are required and precede caspase activation. As protein synthesis is required for caspases and apoptosis activation, DEX-induced GR nuclear translocation is necessary for apoptosis. Cell treatment with geldanamycin (GA) inhibits the GR nuclear translocation and consequently, caspases activation and apoptosis. Although DEX treatment induces loss of mitochondrial membrane potential (Δψm) and cytochrome c release, Δψm induction does not correlate with thymocyte apoptosis. In fact, while Cyclosporin-A and the caspase-9 inhibitor, Z-LEHD-FMK, inhibit DEX-induced Δψm, do not influence apoptosis. These data indicate many biochemical events and are activated by DEX treatment of thymocytes and some, but not all, are required for apoptosis. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.